| Dr Vinca Wing Kar Chow, MD | |
|
1 Medical Center Drive, Dartmouth Hitchcock-anesthesiology & Pain Medicine, Lebanon, NH 03756 | |
| (603) 650-6177 | |
| Not Available |
| Full Name | Dr Vinca Wing Kar Chow |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1 Medical Center Drive, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043575277 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 251436 (Massachusetts) | Secondary |
| 207LP2900X | Anesthesiology - Pain Medicine | 18170 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vinca Wing Kar Chow, MD 1 Medical Center Dr, Dartmouth Hitchcock - Anesthesiology Pain Medicine, Lebanon, NH 03756 Ph: (603) 650-6177 | Dr Vinca Wing Kar Chow, MD 1 Medical Center Drive, Dartmouth Hitchcock-anesthesiology & Pain Medicine, Lebanon, NH 03756 Ph: (603) 650-6177 |
News Archive
"We found signs of early blood vessel damage that could lead to significant symptoms and could end a player's career," said T. Adam Ginn, M.D., chief resident in orthopaedics at Wake Forest Baptist, and one of the study's researchers. "The gloves' current design does not protect the hand from trauma."
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the publication of breakthrough new research in the Proceedings of the National Academy of Sciences (USA). The discovery, centered on the epigenetic enzyme EZH2, illuminates a clear path for the translation of basic science into targeted therapies for the safe and effective treatment of specific forms of human lymphomas.
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (NASDAQ:IPXL), today announced that it has initiated a multinational Phase III trial of its late-stage drug candidate IPX066 in advanced Parkinson's disease (PD) patients.
To date, there is no drug approved for medical therapy of chordoma patients. Supporting research for chordoma (a very rare cancer arising from the skull base or the spine and affecting only one person in a million per year) was the focus of talks that took place on 30 April 2015 at the European Medicines Agency in London. The workshop was attended by patients, oncologists, pathologists, regulators, statisticians and industry representatives.
› Verified 2 days ago
Dr. Matthew James Hoyt, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Dartmouth Hitchcock - Anesthesiology, Lebanon, NH 03756 Phone: 603-650-5922 | |
Marbelia C Gonzalez, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Regina Lee Gritsavage, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Dhmc, Lebanon, NH 03756 Phone: 603-650-5000 | |
Tabitha Antoinette Washington, M.D., B.S. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dhmc Department Of Anesthesiology, Pain Medicine, Lebanon, NH 03756 Phone: 603-650-6040 Fax: 603-650-8199 | |
Dr. Kimberly Youngren, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Stacie G Deiner, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5922 |